Literature DB >> 28509414

The Normal Fetal Pancreas.

Zvi Kivilevitch1, Reuven Achiron2, Sharon Perlman2, Yinon Gilboa2.   

Abstract

OBJECTIVES: The aim of the study was to assess the sonographic feasibility of measuring the fetal pancreas and its normal development throughout pregnancy.
METHODS: We conducted a cross-sectional prospective study between 19 and 36 weeks' gestation. The study included singleton pregnancies with normal pregnancy follow-up. The pancreas circumference was measured. The first 90 cases were tested to assess feasibility.
RESULTS: Two hundred ninety-seven fetuses of nondiabetic mothers were recruited during a 3-year period. The overall satisfactory visualization rate was 61.6%. The intraobserver and interobserver variability had high interclass correlation coefficients of of 0.964 and 0.967, respectively. A cubic polynomial regression described best the correlation of pancreas circumference with gestational age (r = 0.744; P < .001) and significant correlations also with abdominal circumference and estimated fetal weight (Pearson r = 0.829 and 0.812, respectively; P < .001). Modeled pancreas circumference percentiles for each week of gestation were calculated. During the study period, we detected 2 cases with overgrowth syndrome and 1 case with an annular pancreas.
CONCLUSIONS: In this study, we assessed the feasibility of sonography for measuring the fetal pancreas and established a normal reference range for the fetal pancreas circumference throughout pregnancy. This database can be helpful when investigating fetomaternal disorders that can involve its normal development.
© 2017 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  fetus; obstetric ultrasound; pancreas; sonography

Mesh:

Year:  2017        PMID: 28509414     DOI: 10.1002/jum.14233

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  1 in total

1.  Sonographic measurement of the fetal pancreas in women with gestational diabetes.

Authors:  Yinon Gilboa; Michał Krekora; Sharon Perlman; Ron Bardin; Eran Kassif; Reuven Achiron; Katarzyna Zych-Krekora; Piotr Kaczmarek; Mariusz Grzesiak; Zvi Kivilevitch
Journal:  Arch Med Sci       Date:  2021-08-04       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.